Literature DB >> 17242059

Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.

Melissa Drysdale1, Gwyneth Olson, Theresa M Koehler, Mary F Lipscomb, C Rick Lyons.   

Abstract

Effective treatment of anthrax is hampered by our limited understanding of the pathophysiology of Bacillus anthracis infection. We used a genetically complete (pXO1(+) pXO2(+)) virulent B. anthracis strain and four isogenic toxin-null mutants to determine the effects of the anthrax edema toxin (ET; edema factor [EF] plus protective antigen [PA]) and lethal toxin (LT; lethal factor [LF] plus PA) on the host innate response during systemic infection. Using the spleen as an indicator for host response, we found that intravenous inoculation of LT-deficient mutants into C57BL/6 mice significantly increased production of several cytokines over that observed after infection with the parent strain or an EF-deficient mutant. Bacteria producing one or both of the toxins were capable of inducing significant apoptosis of cells present in spleens, whereas apoptosis was greatly reduced in mice infected with nontoxigenic mutants. Mice infected with toxin-producing strains also showed increased splenic neutrophil recruitment compared to mice infected with nontoxigenic strains and neutrophil depletion prior to infection with toxin-producing strains, leading to decreased levels of apoptosis. Together, these studies indicate that anthrax LT suppresses cytokine secretion during infection, but both EF and LF play roles in inducing neutrophil recruitment and enhancing apoptosis. Interestingly, in the absence of LF the effect of EF-induced cell recruitment is further enhanced, perhaps because LF so effectively suppresses the secretion of chemokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242059      PMCID: PMC1865709          DOI: 10.1128/IAI.01712-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax.

Authors:  Melissa Drysdale; Sara Heninger; Julie Hutt; Yahua Chen; C Rick Lyons; Theresa M Koehler
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

2.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

3.  Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin.

Authors:  Altaf Kassam; Sandy D Der; Jeremy Mogridge
Journal:  Cell Microbiol       Date:  2005-02       Impact factor: 3.715

Review 4.  Granulocyte apoptosis and the control of inflammation.

Authors:  C Haslett; J S Savill; M K Whyte; M Stern; I Dransfield; L C Meagher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1994-08-30       Impact factor: 6.237

Review 5.  New insights into the molecular mechanism of interleukin-10-mediated immunosuppression.

Authors:  Gerald Grütz
Journal:  J Leukoc Biol       Date:  2004-11-02       Impact factor: 4.962

6.  Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.

Authors:  G Vitale; R Pellizzari; C Recchi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

7.  On the role of macrophages in anthrax.

Authors:  P C Hanna; D Acosta; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

Authors:  F A Abramova; L M Grinberg; O V Yampolskaya; D H Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Role of macrophage oxidative burst in the action of anthrax lethal toxin.

Authors:  P C Hanna; B A Kruskal; R A Ezekowitz; B R Bloom; R J Collier
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

10.  Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists.

Authors:  Jin Mo Park; Vincent H Ng; Shin Maeda; Richard F Rest; Michael Karin
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

View more
  11 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax.

Authors:  Fabien Dumetz; Grégory Jouvion; Huot Khun; Ian Justin Glomski; Jean-Philippe Corre; Clémence Rougeaux; Wei-Jen Tang; Michèle Mock; Michel Huerre; Pierre Louis Goossens
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

4.  Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.

Authors:  Hitendra S Chand; Melissa Drysdale; Julie Lovchik; Theresa M Koehler; Mary F Lipscomb; C Rick Lyons
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

5.  The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

Authors:  William S Lawrence; Jason M Hardcastle; Douglas L Brining; Lori E Weaver; Cindy Ponce; Elbert B Whorton; Johnny W Peterson
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

6.  Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.

Authors:  Donald Reason; Justine Liberato; Jinying Sun; Jessica Camacho; Jianhui Zhou
Journal:  Toxins (Basel)       Date:  2011-08-09       Impact factor: 4.546

7.  Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release is Nlrp1b/Nalp1b-dependent.

Authors:  Kathleen M Averette; Matthew R Pratt; Yanan Yang; Sara Bassilian; Julian P Whitelegge; Joseph A Loo; Tom W Muir; Kenneth A Bradley
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

8.  Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis.

Authors:  Christopher Bradburne; Myung-Chul Chung; Qin Zong; Karen Schlauch; Derong Liu; Taissia Popova; Anna Popova; Charles Bailey; Dan Soppet; Serguei Popov
Journal:  BMC Immunol       Date:  2008-11-13       Impact factor: 3.615

9.  Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax.

Authors:  Jeffrey A Gold; Yoshihiko Hoshino; Marcus B Jones; Satomi Hoshino; Anna Nolan; Michael D Weiden
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240

10.  Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis.

Authors:  Nina M van Sorge; Celia M Ebrahimi; Shauna M McGillivray; Darin Quach; Mojgan Sabet; Donald G Guiney; Kelly S Doran
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.